The clinical outcomes and safety of dalbavancin as primary and sequential treatment of gram-positive bacteremia with infective endocarditis were evaluated retrospectively. The clinical success rate was high (92.6%), but in 24 of 27 patients dalbavancin was used only after clearance of bacteria from the bloodstream.

中文翻译：

---

达巴万星作为革兰氏阳性感染性心内膜炎的主要和顺序治疗：在维也纳总医院的2年经验。

回顾性评价达巴万星作为革兰氏阳性菌血症合并感染性心内膜炎的一级和序贯治疗的临床结果和安全性。临床成功率很高（92.6％），但在27例患者中有24例达巴万星仅在清除血液中的细菌后才使用。